1. 1) Ministry of Health, Labour and Welfare. “Estimation of future medical care cost and financial influence.”: 〈http://www.mhlw.go.jp/stf/shingi/2r9852000000uhlp-att/2r9852000000uhq0.pdf〉, cited 29 May, 2014.
2. 2) Prime Minister of Japan and His Cabinet. “Japan Revitalisation Strategy-Japan is Back-”: 〈http://www.kantei.go.jp/jp/singi/kokuminkaigi/dai16/sankou3.pdf〉, cited 29 May, 2014.
3. 3) World Health Organization (WHO), “Guidelines for the Regulatory Assessment of Medicinal Products for Use in Self-Medication,” WHO, Geneva, 2000, pp. 4-31.
4. 4) Hara A., Ohkubo T., Obara T., Tsubota-Utsugi M., Kikuya M., Metoki H., Inoue R., Aasayama K., Totsune K., Hoshi H., Hosokawa T., Satoh H., Imai Y., J. Drug Interact. Res., 33, 7-13 (2009).
5. 5) Sato E., Anraku M., Okamura N., Hata T., Yoshitomi H., Taguchi K., Murakami N., Yakugaku Zasshi, 131, 1117-1125 (2011).